Suresh C. Jhanwar

14.0k citations

138 papers · 9.2k indexed · 2 hit papers · h-index 49

Molecular Biology top 1%
Oncology top 0.5%
Pathology and Forensic Medicine top 0.5%
Pulmonary and Respiratory Medicine top 1%
Genetics top 1%

Co-authors: Marc Ladanyi R. S. K. Chaganti Joseph R. Testa Daniel A. Filippa Kenneth Offit Cristina R. Antonescu P. Maslak Zhugang Wang
Topics: Chronic Lymphocytic Leukemia Research (26 papers)Acute Myeloid Leukemia Research (25 papers)Lymphoma Diagnosis and Treatment (24 papers)
Cited by: Hematology Genetics Pathology and Forensic Medicine
Journals: Nature New England Journal of Medicine Cell
Partner nations: United States France Spain

In The Last Decade

Suresh C. Jhanwar

138 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

1998 1.0k citations Suresh C. Jhanwar et al. profile →
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor

2010 604 citations Cristina R. Antonescu, Suresh C. Jhanwar et al. profile →

Peers

Countries citing papers authored by Suresh C. Jhanwar

Since Specialization

Citations

This map shows the geographic impact of Suresh C. Jhanwar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh C. Jhanwar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh C. Jhanwar more than expected).

Fields of papers citing papers by Suresh C. Jhanwar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh C. Jhanwar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh C. Jhanwar. The network helps show where Suresh C. Jhanwar may publish in the future.

Co-authorship network of co-authors of Suresh C. Jhanwar

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh C. Jhanwar. A scholar is included among the top collaborators of Suresh C. Jhanwar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh C. Jhanwar. Suresh C. Jhanwar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects 2023 ·Advances in Biological Regulation ·Abul Elahi,(unknown),Xiaoliang L. Xu,Alexia Eliades,Philippos C. Patsalis,David H. Abramson,Suresh C. Jhanwar	1
2	Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma 2020 ·Clinical Cancer Research ·Yinfei Tan,Eleonora Sementino,Mitchell Cheung,Suraj Peri,Craig W. Menges,(unknown),Ting Zhang,Vladimir Khazak,(unknown),Eric A. Ross,(unknown),Suresh C. Jhanwar,Raja M. Flores,Siddharth Balachandran,Joseph R. Testa	38
3	NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition 2015 ·Cancer Discovery ·María E.R. García-Rendueles,Julio C. Ricarte‐Filho,Brian R. Untch,Iñigo Landa,Jeffrey A. Knauf,Francesca Voza,Vicki E. Smith,Ian Ganly,Barry S. Taylor,Yogindra Persaud,Gisele Oler,Yuqiang Fang,Suresh C. Jhanwar,Agnès Viale,Adriana Heguy,Kety Huberman,Filippo G. Giancotti,Ronald Ghossein,James A. Fagin	99
4	Pharmacologic Targeting of Skp2 in Retinoblastoma 2014 ·Investigative Ophthalmology & Visual Science ·Xiaoliang L. Xu,Timothy Cardozo,Dan‐Ning Hu,David Cobrinik,David H. Abramson,Suresh C. Jhanwar	1
5	Double Minute Chromosomes in Glioblastoma Multiforme Are Revealed by Precise Reconstruction of Oncogenic Amplicons 2013 ·Cancer Research ·Zack Sanborn,Sofie R. Salama,Mia Grifford,Cameron Brennan,Tom Mikkelsen,Suresh C. Jhanwar,Sol Katzman,Lynda Chin,David Haussler	73
6	A Genome-Wide High-Resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation 2013 ·Journal of Molecular Diagnostics ·Lu Wang,(unknown),Yuqiang Fang,Meera Hameed,Agnès Viale,Klaus J. Busam,Suresh C. Jhanwar	65
7	IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma 2012 ·Clinical Cancer Research ·Daniel Gorovets,Kasthuri Kannan,Ronglai Shen,Edward R. Kastenhuber,(unknown),Carl Campos,Elena Pentsova,Adriana Heguy,Suresh C. Jhanwar,Ingo K. Mellinghoff,Timothy A. Chan,Jason T. Huse	114
8	The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy-Induced Apoptosis of p53 -Mutated Multiple Myeloma Cells 2012 ·Molecular Cancer Therapeutics ·Heather Landau,Samuel McNeely,Jayasree S. Nair,Raymond L. Comenzo,Takashi Asai,(unknown),Suresh C. Jhanwar,Stephen D. Nimer,Gary K. Schwartz	48
9	Chromothripsis in a case of TP53-deficient chronic lymphocytic leukemia 2012 ·Leukemia Research Reports ·Jianming Pei,Suresh C. Jhanwar,Joseph R. Testa	10
10	Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1. 2009 ·PubMed ·Yuqiang Fang,Abul Elahi,(unknown),Pulivarthi H. Rao,Murray F. Brennan,Suresh C. Jhanwar	22
11	Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling 2009 ·Cell ·Xiaoliang L. Xu,Yuqiang Fang,Thomas C. Lee,Douglas Forrest,Cheryl Y. Gregory‐Evans,Dena Almeida,Aihong Liu,Suresh C. Jhanwar,David H. Abramson,David Cobrinik	175
12	A Novel Recurrent Chromosomal Inversion Implicates the Homeobox Gene Dlx5 in T-Cell Lymphomas from Lck-Akt2 Transgenic Mice 2008 ·Cancer Research ·Yinfei Tan,(unknown),(unknown),Deborah A. Altomare,Jinfei Xu,Zemin Liu,Qingshen Gao,Suresh C. Jhanwar,Antonio Di Cristofano,David L. Wiest,Janice E. Knepper,Joseph R. Testa	29
13	The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression 2005 ·Molecular and Cellular Biology ·Guang‐Hui Xiao,Ryan J. Gallagher,(unknown),Kristine L. Skele,Deborah A. Altomare,Richard G. Pestell,Suresh C. Jhanwar,Joseph R. Testa	141
14	Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines 2001 ·Oncogene ·Donal MacGrogan,Sara Álvarez,Tony DeBlasio,Suresh C. Jhanwar,Stephen D. Nimer	28
15	Specificity of TLS-CHOP Rearrangement for Classic Myxoid/Round Cell Liposarcoma 2000 ·Journal of Molecular Diagnostics ·Cristina R. Antonescu,Abul Elahi,(unknown),Man Yee Lui,John H. Healey,Murray F. Brennan,James M. Woodruff,Suresh C. Jhanwar,Marc Ladanyi	89
16	The Spectrum of Somatic Mutations in thePIG-AGene in Paroxysmal Nocturnal Hemoglobinuria Includes Large Deletions and Small Duplications 1998 ·Blood Cells Molecules and Diseases ·Khédoudja Nafa,Monica Bessler,Hugo Castro‐Malaspina,Suresh C. Jhanwar,Lucio Luzzatto	69
17	Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer 1996 ·Nature Genetics ·Susan L. Neuhausen,Teresa Gilewski,Larry Norton,Thao Tran,Peter J. McGuire,Jeffrey Swensen,Heather Hampel,Patrick I. Borgen,Karen Brown,Mark H. Skolnick,Donna Shattuck-Eidens,Suresh C. Jhanwar,David E. Goldgar,Kenneth Offit	219
18	The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% 1996 ·Nature Genetics ·(unknown),Jeffery P. Struewing,(unknown),Susan L. Neuhausen,Lawrence C. Brody,Michael M. Kaback,Bruce R. Haas,Larry Norton,Patrick I. Borgen,Suresh C. Jhanwar,David E. Goldgar,Harry Ostrer,Kenneth Offit	298
19	Hormonal Regulation of the p53 Tumor Suppressor Protein in T47D Human Breast Carcinoma Cell Line 1995 ·Journal of Biological Chemistry ·Cliff Hurd,Nidhi Khattree,(unknown),(unknown),Suresh C. Jhanwar,Sumi Dinda,V.K. Moudgil	69
20	Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12) 1990 ·Human Pathology ·Marc Ladanyi,F. Scott Heinemann,Andrew G. Huvos,Pulivarthi H. Rao,(unknown),Suresh C. Jhanwar	74

About Suresh C. Jhanwar

Suresh C. Jhanwar is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 138 papers that have together received 9.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (26 papers), Acute Myeloid Leukemia Research (25 papers) and Lymphoma Diagnosis and Treatment (24 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (1.2k citations) and Pathology and Forensic Medicine (2.0k citations). Suresh C. Jhanwar has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Marc Ladanyi, R. S. K. Chaganti, Joseph R. Testa, Daniel A. Filippa, Kenneth Offit, Cristina R. Antonescu, P. Maslak, Zhugang Wang, Raymond P. Warrell and Janice Gabrilove. Their work appears in journals such as Nature, New England Journal of Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact